|
 |
European Pharmaceutical Contractor
|
One of the biggest challenges facing pharmaceutical companies today is the expedient and successful recruitment of candidates into clinical trial programmes. The area of clinical trial recruitment is one of increasing competition and yet many sponsor companies do not consider implementing marketing communications strategies at all, whereas many others fail to recognise the importance of such campaigns early enough in the trial development process.
The Facts are Startlingly Clear
It is estimated that 80 per cent of all clinical trials will fall short of their recruitment targets each year, while it is estimated that 75 per cent of these studies will fail to meet enrolment deadlines (1). Indeed, a CenterWatch Europe survey revealed that patient recruitment and retention were the most frequently cited causes of delays in 40 per cent of studies (2). Nonetheless, for some pharmaceutical companies, the concept of utilising communications strategies to assist in patient recruitment and retention is still relatively new outside of the USA.
|
Read full article >>
|
|
 |
|
| Rate this article |
You must be a member of the site to make a vote. |
|
Average rating: |
0 |
| | | | | |
|
|
 |
Industry Events |
 |
4th Annual Patient Recruitment and Retention in Clinical Trials
13-15 October 2008, Amsterdam
Patient recruitment
is now consuming thirty percent of clinical trial time - more time than any
other clinical trial activity - and almost half of all trial delays result from
patient recruitment problems.
As the
recruiting culture becomes more sophisticated and the forces affecting patient
enrollment grow more numerous and complex, pharmaceutical companies are
striving to discover new strategies to facilitate enrollment in clinical
trials.
With
increasing industry pressure to develop, test and market greater numbers of new
drugs faster, pharmaceutical companies need to perform clinical trials as
quickly as possible. Inefficient patient recruitment processes is a formidable
barrier to pharmaceutical companies' success in launching new products.
Improving the patient recruitment process is imperative to avoid wasted
investments and eliminate costly delays in bringing new drugs to market --
today and even more so in the not-so-distant future. Improved patient
recruitment presents one of the largest opportunities for pharmaceutical
companies to eliminate delays in clinical trials, thereby making it possible to
reduce time to market. With patent time limits and large overheads
meaning that any delays in the development timeline can be disastrous, a good
understanding of how to successfully recruit patients for trials is vital for
any company looking to succeed.
More info >> |
|
 |
News and Press Releases |
 |
New PFA SonicLineŽ ultrasonic flowmeters
Flow measurement with ultrasound fast, precise, free from contamination The new PFA SonicLineŽ ultrasonic flowmeters assure precise measurement and control of chemical consumption and management of chemical stocks with high reliability. SonicLineŽ is also ideally suited for accurate batch and dosing processes with high reproducibility.
More info >> |
|
 |
